Number and Function of Endothelial Progenitor Cells as a Marker of Severity for Diabetic Vasculopathy
Top Cited Papers
- 1 September 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 26 (9), 2140-2146
- https://doi.org/10.1161/01.atv.0000237750.44469.88
Abstract
Objective— Peripheral arterial disease (PAD) is a threatening complication of diabetes. As endothelial progenitor cells (EPCs) are involved in neovasculogenesis and maintenance of vascular homeostasis, their impairment may have a role in the pathogenesis of diabetic vasculopathy. This study aimed to establish whether number and function of EPCs correlate with PAD severity in type 2 diabetic patients. Methods and Results— EPCs were defined by the expression of CD34, CD133 and KDR, and quantified by flow cytometry in 127 diabetic patients with and without PAD. PAD severity has been assessed as carotid atherosclerosis and clinical stage of leg atherosclerosis obliterans. Diabetic patients with PAD displayed a significant 53% reduction in circulating EPCs versus non-PAD patients, and EPC levels were negatively correlated with the degree of carotid stenosis and the stage of leg claudication. Moreover, the clonogenic and adhesion capacity of cultured EPCs were significantly lower in diabetic patients with PAD v... Endothelial progenitor cells (EPCs) have been implicated in adult neovasculogenesis and maintenance of endothelial homeostasis. In this study, we provide evidence that number and function of EPCs correlate with severity of peripheral atherosclerosis in type 2 diabetic patients.Keywords
This publication has 31 references indexed in Scilit:
- Granulocyte Colony-Stimulating Factor–Mobilized Circulating c-Kit+/Flk-1+ Progenitor Cells Regenerate Endothelium and Inhibit Neointimal Hyperplasia After Vascular InjuryArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Influence of Cardiovascular Risk Factors on Endothelial Progenitor CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Circulating Endothelial Progenitor Cells and Cardiovascular OutcomesNew England Journal of Medicine, 2005
- Reduced Number of Circulating Endothelial Progenitor Cells Predicts Future Cardiovascular EventsCirculation, 2005
- Circulating Endothelial Progenitor Cells Are Reduced in Peripheral Vascular Complications of Type 2 Diabetes MellitusJournal of the American College of Cardiology, 2005
- Endothelial Progenitor Cell DysfunctionDiabetes, 2004
- Endothelial Progenitor CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Human Endothelial Progenitor Cells From Type II Diabetics Exhibit Impaired Proliferation, Adhesion, and Incorporation Into Vascular StructuresCirculation, 2002
- Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implicationsCardiovascular Research, 2001
- Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularizationNature Medicine, 1999